2018 CPR update: AHA issues pediatric, adult recommendations


  • Jenny Blair, MD
  • Clinical Essentials
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • For resuscitation of cardiac arrest with ventricular fibrillation (VF)/pulseless ventricular tachycardia (pVT), lidocaine is an option for a first-line treatment.  
  • Pediatric advanced life support (PALS) recommendations remain unchanged.

Why this matters

  • Improving survival after cardiac arrest remains a key public-health challenge. 

Description

  • International Liaison Committee on Resuscitation second annual review of CPR literature.
  • 2018 American Heart Association (AHA) update regarding advanced cardiovascular life support: specifically, antiarrhythmic medications for adult and pediatric cardiac arrest and during return of spontaneous circulation (ROSC).

Key details

  • Adults with shock-refractory VF/pVT:
    • Authors suggest amiodarone or lidocaine, especially in witnessed arrest (weak recommendation, low-quality evidence [WR/LQE]).
    • They advise against routine magnesium (WR, very LQE).
    • Not enough evidence to make recommendations concerning bretylium, nifekalant, or sotalol, nor about antiarrhythmic prophylaxis during ROSC.
  • Consider magnesium for adults experiencing torsades de pointes (WR/LQE).
  • Adults with ROSC immediately after cardiac arrest:
    • Insufficient evidence to advise in favor of or against routine beta-blockade or lidocaine in first hour.
    • Consider prophylactic lidocaine if treatment of recurrent VF/pVT would be difficult, such as during transport (WR).
  • Infants and children with shock-refractory VF/pVT arrest: 
    • Authors suggest amiodarone or lidocaine (WR, very LQE based on 1 study; recommendation unchanged since 2015).

Please confirm your acceptance

To gain full access to GPnotebook please confirm:

By submitting here you confirm that you have accepted Terms of Use and Privacy Policy of GPnotebook.

Submit